Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells
- 86 Downloads
To elucidate the pathogenic mechanisms involved in neurodegeneration in AIDS patients with cognitive deficits, we have examined the toxic effect of the lentivirus lytic peptide 1 (LLP-1) corresponding to the carboxyl terminus of HIV-1 transmembrane glycoprotein gp41 on human neuronal and glial cell lines. LLP-1 induced a significant lactate dehydrogenase (LDH, a marker of cell death) release from these cells in a concentration- and time-dependent manner, while the noncytolytic LLP-1 analog 2 had little effect. Application of LLP-1 to SH-SY5Y, a well-characterizedhuman neuronal cell line, causedthe decline of intracellular glutathione (GSH) content that appeared to occur before a significant LDH release. Furthermore, LLP-1 elicited a significant loss of mitochondrial function as measured by mitochondrial transmembrane potential (MTP). Among the reducing agents and antioxidants tested, GSH and a GSH prodrug N-acetylcysteine (NAC) provided protection against LLP-1-induced neuronal cell death, evidently by restoring the intracellular GSH levels and blocking the disruption of mitochondrial integrity. Thus, gp41-derived LLP-1 may be a potential neurotoxic agent capable of causing the intracellular GSH depletion and disturbing the mitochondrial function, possibly contributing to the neurodegenerative cascade as seen in HIV-1-associated dementia. Our data indicate that restoring both GSH concentration and mitochondrial function may hold promise as possible therapeutic strategies for slowing disease progression of dementia in AIDS patients.
KeywordsHIV-1-associated dementia gp41 glutathione depletion mitochondrial transmembrane potential N-acetyl cysteine
Unable to display preview. Download preview PDF.
- Chong YH, Lee MJ (2000). Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides. J Neuro Virol 6: 51–60.Google Scholar
- Comardelle AM, Norris CH, Plymale DR, Gatti PJ, Choi B, Fermin CD, Haislip AM, Tencza SB, Mietzner TA, Montelaro RC, Garry RF (1997). A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes. AIDS Res Hum Retro 13: 1525–1532.CrossRefGoogle Scholar
- Cooper JJL (1997). Glutathione in the brain: Disorders of glutathione metabolism. In: The molecular and genetic basis of neurological disease. Barchi RL, Kunk LM (eds). Butterworth-Heinemann: Boston, pp 1195–1230.Google Scholar
- Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, Richman DD, Carson DA, Corbeil J, Leoni LM (2001). HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASER J 15: 5–6.Google Scholar
- Macho A, Castedo M, Marchetti P, Aguilar JJ, Decaudin D, Zamzami N, Girard PM, Uriel J, Kroemer G (1995). Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Rlood 86: 2481–2487.Google Scholar
- Marschang P, Kruger U, Ochsenbauer C, Gurtler L, Hittmair A, Bosch V, Patsch JR, Dierich MP (1997). Complement activation by HIV-1 infected cells: The role of transmembrane glycoprotein gp41. J AIDS Hum Retrovirol 14: 102–109.Google Scholar
- Rostasy K, Monti L, Yiannoutsos C, Kneissl M, Bell J, Kemper TL, Hedreen JC, Navia BA (1999). Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex. Ann Neurol 46: 207–216.CrossRefPubMedGoogle Scholar
- Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A (1997). JC-1, but not DiOC6(3) or rhodamine 123, is areliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411: 77–82.CrossRefPubMedGoogle Scholar